Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke

NCT04415164 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

480

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: Xueshuantong lyophilized powder
DRUG: Placebo
OTHER: Guidelines-based standard care

Sponsor

Dongzhimen Hospital, Beijing

Collaborators

[object Object]